Clorox Analysts Boost Their Forecasts Following Upbeat Earnings

Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell.

Clorox reported fiscal second-quarter revenue of $1.69 billion, beating the consensus estimate of $1.63 billion, according to Benzinga Pro. The household consumer products company reported adjusted earnings of $1.55 per share, beating analyst estimates of $1.41 per share.

"We achieved better-than-expected results across sales, margin and EPS in the second quarter due to our strong demand creation plans, which also supported our share growth," said Linda Rendle, chair and CEO of Clorox. "We are further advancing our transformation as we embark upon a significant milestone with our Enterprise Resource Planning transition in the U.S., resulting in our updated outlook. I am confident that we are taking the right actions to deliver strong financial performance and long-term, profitable growth."

Clorox raised its full-year earnings forecast from a range of $6.65 to $6.90 per share to a new range of $6.95 to $7.35 per share versus estimates of $6.84 per share. The company also guided for 2025 net sales in a range of down 1% to up 2%.

Clorox shares fell 6.6% to trade at $149.19 on Tuesday.

These analysts made changes to their price targets on Clorox following earnings announcement.

• Wells Fargo analyst Chris Carey maintained Clorox with an Equal-Weight and raised the price target from $157 to $161.
• JP Morgan analyst Andrea Teixeira maintained Clorox with a Neutral and raised the price target from $171 to $173.

Considering buying CLX stock? Here’s what analysts think:

Read This Next:

• McDonald’s To $290? Here Are 10 Top Analyst Forecasts For Tuesday